Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Charles A Veltri

Biographic Data

ID7296353
NAMECharles A Veltri
GIVEN NAMESCharles A
FAMILY NAMEVeltri
SIGNATUREVELTRI C A
AFFILIATIONSMidwestern University
ORCID0000-0001-7626-1555
VERIFIEDYes
TOTAL WORKS8
TOTAL CITATIONS0
AUTHOR COUNT8
EDITOR COUNT0
FIRST PUBLICATION YEAR2019
LATEST PUBLICATION YEAR2026
H-INDEX0
  • Diversification of Kratom in US Markets: Results from an Online Survey and Chemical Assay of Products

    KATHERINE HILL, Allison Henderson et al.•ARTICLE•Substance Use & Misuse•2026

    ) products in the US have diversified from dried leaf to now include edibles, extracts, teas, and tonics. Higher alkaloid content and/or greater oral exposure across formulations expose consumers to potentially greater amounts of alkaloids per serving in a shorter duration of time, thereby potentially increasing product effect and risk profiles. Six kratom vendors disseminated our anonymous online survey. Participants reported on products use pat…

  • Kratom as a potential substance use disorder harm reduction agent

    Open Access•MeShell Green, Nina Vadiei et al.•ARTICLE•Frontiers in Public Health•2024

    Substance use disorders contribute to considerable U.S. morbidity and mortality. While effective pharmacotherapy options are available to treat opioid and alcohol use disorders, for a variety of reasons, many patients lack access to treatment or may be reluctant to seek care due to concerns such as perceived stigma or a current lack of desire to completely curtail their substance use. Furthermore, treatment options are limited for patients with s…

  • Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report

    Open Access•Oliver Grundmann, Kirsten E Smith et al.•ARTICLE•Frontiers in Psychiatry•2024

  • Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects

    Open Access•Oliver Grundmann, KATHERINE HILL et al.•ARTICLE•Journal of Ethnopharmacology•2023

  • Current and Future Potential Impact of Covid-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use

    Open Access•Darshan Singh, Paula N Brown et al.•ARTICLE•Frontiers in Psychiatry•2020

    Kratom ( Mitragyna speciosa Korth., Rubiaceae) is native to and has traditional use in Southeast Asia. The number of kratom users outside of Southeast Asia has increased significantly in recent decades with use spreading to the Unites States (US) and Europe. Because of its reputed opioid-like psychoactive effects at higher doses, kratom has been regulated in several countries and is subject to an import ban by the US Food and Drug Administration.…

  • Can Kratom (Mitragyna speciosa) Alleviate Covid-19 Pain? A Case Study

    Open Access•Antonio Metastasio, Elisabeth Prevete et al.•ARTICLE•Frontiers in Psychiatry•2020

    Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned s…

  • Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago

    Open Access•Walter C Prozialeck, Joshua Edwards et al.•ARTICLE•International Journal of…•2020

    Kratom ( Mitragyna speciosa , Korth) is a tree-like plant that is indigenous to Southeast Asia. Kratom leaf products have been used in traditional folk medicine for their unique combination of stimulant and opioid-like effects. Kratom is being increasingly used in the West for its reputed benefits in the treatment of pain, depression and opioid use disorder. Recently, the United States Food and Drug Administration and Centers for Disease Control …

  • Kratom policy: The challenge of balancing therapeutic potential with public safety

    Open Access•Walter C Prozialeck, Bonnie A Avery et al.•ARTICLE•International Journal of Drug…•2019

    Kratom (Mitragyna speciosa) is a tree-like plant indigenous to Southeast Asia. Its leaves, and the teas brewed from them have long been used by people in that region to stave off fatigue and to manage pain and opioid withdrawal. Evidence suggests kratom is being increasingly used by people in the United States and Europe for the self-management of opioid withdrawal and treatment of pain. Recent studies have confirmed that kratom and its chemical …

No prominent works on this page.

  • Kratom policy: The challenge of balancing therapeutic potential with public safety

    Open Access•Walter C Prozialeck, Bonnie A Avery et al.•ARTICLE•International Journal of Drug…•2019

    Kratom (Mitragyna speciosa) is a tree-like plant indigenous to Southeast Asia. Its leaves, and the teas brewed from them have long been used by people in that region to stave off fatigue and to manage pain and opioid withdrawal. Evidence suggests kratom is being increasingly used by people in the United States and Europe for the self-management of opioid withdrawal and treatment of pain. Recent studies have confirmed that kratom and its chemical …

  • Current and Future Potential Impact of Covid-19 on Kratom (Mitragyna speciosa Korth.) Supply and Use

    Open Access•Darshan Singh, Paula N Brown et al.•ARTICLE•Frontiers in Psychiatry•2020

    Kratom ( Mitragyna speciosa Korth., Rubiaceae) is native to and has traditional use in Southeast Asia. The number of kratom users outside of Southeast Asia has increased significantly in recent decades with use spreading to the Unites States (US) and Europe. Because of its reputed opioid-like psychoactive effects at higher doses, kratom has been regulated in several countries and is subject to an import ban by the US Food and Drug Administration.…

  • Can Kratom (Mitragyna speciosa) Alleviate Covid-19 Pain? A Case Study

    Open Access•Antonio Metastasio, Elisabeth Prevete et al.•ARTICLE•Frontiers in Psychiatry•2020

    Among the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned s…

  • Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago

    Open Access•Walter C Prozialeck, Joshua Edwards et al.•ARTICLE•International Journal of…•2020

    Kratom ( Mitragyna speciosa , Korth) is a tree-like plant that is indigenous to Southeast Asia. Kratom leaf products have been used in traditional folk medicine for their unique combination of stimulant and opioid-like effects. Kratom is being increasingly used in the West for its reputed benefits in the treatment of pain, depression and opioid use disorder. Recently, the United States Food and Drug Administration and Centers for Disease Control …

  • Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects

    Open Access•Oliver Grundmann, KATHERINE HILL et al.•ARTICLE•Journal of Ethnopharmacology•2023

  • Kratom as a potential substance use disorder harm reduction agent

    Open Access•MeShell Green, Nina Vadiei et al.•ARTICLE•Frontiers in Public Health•2024

    Substance use disorders contribute to considerable U.S. morbidity and mortality. While effective pharmacotherapy options are available to treat opioid and alcohol use disorders, for a variety of reasons, many patients lack access to treatment or may be reluctant to seek care due to concerns such as perceived stigma or a current lack of desire to completely curtail their substance use. Furthermore, treatment options are limited for patients with s…

  • Commentary: Presence of kratom in opioid overdose deaths: findings from coroner postmortem toxicological report

    Open Access•Oliver Grundmann, Kirsten E Smith et al.•ARTICLE•Frontiers in Psychiatry•2024

  • Diversification of Kratom in US Markets: Results from an Online Survey and Chemical Assay of Products

    KATHERINE HILL, Allison Henderson et al.•ARTICLE•Substance Use & Misuse•2026

    ) products in the US have diversified from dried leaf to now include edibles, extracts, teas, and tonics. Higher alkaloid content and/or greater oral exposure across formulations expose consumers to potentially greater amounts of alkaloids per serving in a shorter duration of time, thereby potentially increasing product effect and risk profiles. Six kratom vendors disseminated our anonymous online survey. Participants reported on products use pat…

Alkaloids: synthesis and pharmacology (8 works) · Medicine (7 works) · Traditional and Medicinal Uses of Annonaceae (6 works) · Berberine and alkaloids research (4 works) · Opioid (4 works) · Traditional medicine (4 works) · Business (3 works) · Chemical synthesis and alkaloids (3 works) · Psychiatry (3 works) · Chemistry (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae